The FDA’s Acyclovir IVPT guidance can be complicated. During this presentation, we will review the FDA’s draft guidance, discuss its strengths and weaknesses, and offer suggestions for strengthening the test.
Following the presentation, you’ll have a valuable and unique opportunity to gain expert answers to your questions specific to IVPT in your lab. Teledyne Hanson representative Bruna Lousada also will offer information on the company’s IVPT-related instruments, products and services.
- Clive Roper, director of Roper Toxicology Consulting Ltd.
- Frank Toner, associate director of In Vitro Dermal Services at Charles River Laboratories
A video recording of the webinar is now available. Click here to watch.
The presentation is sponsored by Teledyne Hanson, the leading global technology company specializing in analytical test instruments for the pharmaceutical industry for more than 70 years.